Agilent Technologies, Inc. logo A - Agilent Technologies, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 31
HOLD 8
SELL 1
STRONG
SELL
0
| PRICE TARGET: $153.25 DETAILS
HIGH: $165.00
LOW: $140.00
MEDIAN: $152.50
CONSENSUS: $153.25
UPSIDE: 18.73%

About Agilent Technologies, Inc. (https://www.agilent.com)

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Key Executives

NAME TITLE DOB SALARY
Padraig McDonnell Chief Executive Officer, President & Director 1972 $2,639,627 USD
Simon May Senior VP and President of Life Sciences & Diagnostics Markets Group 1973 $1,625,186 USD
Bret DiMarco Senior VP & Secretary 1968 $1,176,848 USD
Michael Buckner Senior Vice President, Chief Legal Officer, & Secretary $1,176,848 USD
Angelica Riemann Senior VP & President of Agilent CrossLab Group 1971 $1,124,756 USD
Rodney Gonsalves Vice President of Finance 1966 $832,080 USD
Adam S. Elinoff Senior Vice President, Chief Financial Officer & Principal Financial Officer 1978
August Specht Senior Vice President & Chief Technology Officer
Frederick Schwarz Senior VP, Chief Strategy & Corporate Development Officer
Meghan A. Henson Senior Vice President & Chief Human Resources Officer 1970
Tejas Rajeev Savant Vice President of Investor Relations
Tim Downs VP & Chief Accounting Officer 1981
Yvonne Mackie MD of UK & Ireland Operations and Vice President of Human Resources - Europe

Company Peers

Peer analysis pending, check back in 1-2 minutes.